DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vivelle-DOT (Estradiol) - Insomnia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Insomnia (12)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vivelle-DOT (Estradiol) where reactions include insomnia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: female, weighing 45.4 kg (99.8 pounds)

Reactions: Weight Decreased, Tinnitus, Headache, Fatigue, Malaise, Dyspepsia, Neck Pain, Depression, Decreased Appetite, Nausea, Cognitive Disorder, Self Injurious Behaviour, Muscle Twitching, Tremor, Insomnia, Dehydration, Nervous System Disorder, Memory Impairment, Blood Pressure Decreased, Asthenia

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Tylenol; Aspirin



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-08-09

Patient: female

Reactions: Weight Decreased, Tinnitus, Nausea, Cognitive Disorder, Headache, Self Injurious Behaviour, Muscle Twitching, Tremor, Fatigue, Malaise, Dyspepsia, Insomnia, Memory Impairment, Depression, Asthenia, Blood Pressure Decreased, Decreased Appetite

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Aspirin; Tylenol



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-08-02

Patient: female

Reactions: Weight Decreased, Tinnitus, Nausea, Headache, Cognitive Disorder, Muscle Twitching, Tremor, Fatigue, Malaise, Dyspepsia, Insomnia, Depression, Memory Impairment, Blood Pressure Decreased, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Aspirin; Tylenol (Caplet)



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-12

Patient: female

Reactions: Weight Decreased, Night Sweats, Back Pain, Wrong Technique in Drug Usage Process, Drug Ineffective, Nausea, Cystocele, Hot Flush, Fatigue, Insomnia, Enterocele, Multiple Sclerosis, Menopausal Symptoms

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient: female

Reactions: Weight Decreased, Night Sweats, Back Pain, Wrong Technique in Drug Usage Process, Drug Ineffective, Nausea, Cystocele, Hot Flush, Fatigue, Insomnia, Enterocele, Multiple Sclerosis, Menopausal Symptoms

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-26

Patient: female

Reactions: Hot Flush, Drug Ineffective, Insomnia, Depression

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in 67 year old female

Reported by a consumer/non-health professional from United States on 2012-03-26

Patient: 67 year old female, weighing 13.6 kg (29.9 pounds)

Reactions: Weight Increased, Insomnia, Feeling Abnormal

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a individual with unspecified qualification from United States on 2011-12-14

Patient: female

Reactions: Hypersensitivity, Drug Ineffective, Urticaria, Sleep Talking, Pyrexia, Erythema, Application Site Pruritus, Abdominal Discomfort, Malaise, Pharyngeal Oedema, Oedema Peripheral, Cold Sweat, Muscle Spasms, Pain in Extremity, Application Site Pain, Application Site Rash, Middle Insomnia, Insomnia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Antibiotics

Flagyl

Metoprolol Succinate
    Dosage: 50 mg, qd

Ranitidine Hydrochloride
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Vivelle-DOT
    Dosage: 0.05 mg, qw2
    Start date: 1995-01-01

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Other drugs received by patient: Ascorbic Acid; Vitamin E; Vitamin B NOS; Naproxen Sodium; Vitamin D; Zinc; Similasan; Toprol-XL; Vitamin A; Potassium Chloride; Tylenol-500; Equate (Acetylsalicylic Acid); Zantac



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-30

Patient: female, weighing 61.7 kg (135.7 pounds)

Reactions: Pharyngeal Inflammation, Asthma, Increased Upper Airway Secretion, Dysphagia, Upper-Airway Cough Syndrome, Hot Flush, DRY Mouth, Insomnia, DRY Throat, Nasal Inflammation, Nasal Dryness, Cough, Aphonia

Drug(s) suspected as cause:
Azelastine HCL
    Dosage: one or two puffs as needed
    Indication: Upper-Airway Cough Syndrome
    Start date: 2011-01-01

Climara
    Start date: 2011-01-01
    End date: 2011-10-03

Climara
    Dosage: eleven plus years ago

Climara
    Indication: Hysterectomy
    Start date: 2011-01-01
    End date: 2011-01-01

Climara
    Start date: 2011-01-01

Medrol
    Indication: Increased Upper Airway Secretion
    Start date: 2011-01-01
    End date: 2011-01-01

Medrol
    Indication: Cough
    Start date: 2011-01-01
    End date: 2011-01-01

Vivelle-DOT
    Indication: Hysterectomy
    Start date: 2011-01-01
    End date: 2011-01-01

Zithromax
    Indication: Cough
    Start date: 2011-01-01
    End date: 2011-01-01

Zithromax
    Start date: 2011-01-01
    End date: 2011-01-01

Zithromax
    Dosage: as per the course
    Indication: Increased Upper Airway Secretion
    Start date: 2011-01-01
    End date: 2011-01-01

Zithromax
    Dosage: as per the course
    Start date: 2011-01-01
    End date: 2011-01-01

Zyrtec
    Dosage: splitting the tablets in half
    Administration route: Oral
    Indication: Antiallergic Therapy
    Start date: 2011-01-01

Zyrtec
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Other drugs received by patient: Cozaar



Possible Vivelle-DOT side effects in female

Reported by a individual with unspecified qualification from United States on 2011-11-28

Patient: female

Reactions: Hypersensitivity, Drug Ineffective, Urticaria, Sleep Talking, Pyrexia, Erythema, Application Site Pruritus, Abdominal Discomfort, Pharyngeal Oedema, Malaise, Oedema Peripheral, Cold Sweat, Muscle Spasms, Pain in Extremity, Application Site Rash, Insomnia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Antibiotics

Flagyl

Metoprolol Succinate
    Dosage: 50 mg, qd

Ranitidine Hydrochloride
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Vivelle-DOT
    Dosage: 0.05 mg, qw2
    Start date: 1995-01-01

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Other drugs received by patient: Similasan; Zinc; Vitamin A; Naproxen Sodium; Equate (Acetylsalicylic Acid); Zantac; Ascorbic Acid; Vitamin E; Potassium Acetate; Toprol-XL; Vitamin D; Vitamin B NOS; Tylenol-500



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-18

Patient: female, weighing 61.7 kg (135.7 pounds)

Reactions: Asthma, Pharyngeal Inflammation, Increased Upper Airway Secretion, Dysphagia, Upper-Airway Cough Syndrome, Hot Flush, Insomnia, DRY Throat, DRY Mouth, Nasal Inflammation, Nasal Dryness, Cough, Aphonia

Drug(s) suspected as cause:
Azelastine HCL
    Dosage: one or two puffs as needed
    Indication: Upper-Airway Cough Syndrome
    Start date: 2011-01-01

Climara
    Dosage: eleven plus years ago

Climara
    Indication: Hysterectomy
    Start date: 2011-01-01
    End date: 2011-01-01

Climara
    Start date: 2011-01-01
    End date: 2011-10-03

Climara
    Start date: 2011-01-01

Medrol
    Indication: Increased Upper Airway Secretion
    Start date: 2011-01-01
    End date: 2011-01-01

Medrol
    Indication: Cough
    Start date: 2011-01-01
    End date: 2011-01-01

Vivelle-DOT
    Indication: Hysterectomy
    Start date: 2011-01-01
    End date: 2011-01-01

Zithromax
    Dosage: as per the course
    Start date: 2011-01-01
    End date: 2011-01-01

Zithromax
    Start date: 2011-01-01
    End date: 2011-01-01

Zithromax
    Indication: Cough
    Start date: 2011-01-01
    End date: 2011-01-01

Zithromax
    Dosage: as per the course
    Indication: Increased Upper Airway Secretion
    Start date: 2011-01-01
    End date: 2011-01-01

Zyrtec
    Dosage: splitting the tablets in half
    Administration route: Oral
    Indication: Antiallergic Therapy
    Start date: 2011-01-01

Zyrtec
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Other drugs received by patient: Cozaar



Possible Vivelle-DOT side effects in 60 year old female

Reported by a consumer/non-health professional from United States on 2011-11-18

Patient: 60 year old female, weighing 61.7 kg (135.7 pounds)

Reactions: Aphagia, Asthma, Nightmare, Increased Upper Airway Secretion, Upper-Airway Cough Syndrome, Upper Respiratory Tract Inflammation, Hot Flush, Insomnia, DRY Throat, DRY Mouth, Nasal Dryness, Cough, Aphonia

Drug(s) suspected as cause:
Climara
    Dosage: 0375 mg, unk
    Indication: Hysterectomy
    Start date: 2011-01-01
    End date: 2011-10-03

Climara
    Dosage: 0.375 mg, unk
    Indication: Autonomic Nervous System Imbalance
    Start date: 2000-01-01

Vivelle-DOT
    Dosage: 0.275 mg, q2wk
    Indication: Hysterectomy
    Start date: 2011-01-01

Other drugs received by patient: Losartan

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017